VisualDx Awarded New Grant to Help Integrate Clinical Decision Support for Ultrasound Imaging in Space for NASA
New Software Will Leverage the VisualDx Expert System for Space Travel
VisualDx, the leading diagnostic clinical decision support tool for physicians, announced it has been awarded a grant from the Translational Research Institute for Space Health(TRISH) at Baylor College of Medicine (BCM) to provide integrated clinical decision support for ultrasound imaging during deep space flight. TRISH has a cooperative agreement with the National Aeronautics and Space Administration (NASA). VisualDx was awarded a separate grant in August 2018 to conduct research related to artificial intelligence for point-of-care diagnostics during space travel as well.
Spaceflight mission on-board medical diagnostic systems need to provide user-guidance capabilities or minimize training time by being exceptionally intuitive and easy to use. Therefore, using its proprietary technology, VisualDx was selected for the TRISH grant to create a stand-alone version of its platform that will allow for use with no required internet connection. VisualDx is well qualified to contextualize ultrasound imaging into the broader diagnostic evaluative process to enhance astronaut capability for self-directed medical care when telemedical help from Earth-based physicians is delayed or unavailable.
“We understand the reality that imaging and diagnostic modalities are limited during deep space flight,” said Dr. Art Papier, CEO of VisualDx. “While astronauts may have PhDs, they aren’t physicians, which is why we’re thrilled to have been tapped by TRISH to provide integrated clinical decision support for ultrasound imaging during space flights.”
The goal is to empower non-specialists with basic guidance in ultrasound image interpretation and differential building to quickly and accurately identify a set of potential diagnoses and answer clinical questions while delivering the best care.
“Given our experience with VisualDx on the last grant they were awarded to conduct research related to artificial intelligence for point-of-care diagnostics during space travel, we are funding them again to leverage their technology in other ways,” said Emmanuel Urquieta, M.D., M.S., scientist at the Institute. “We look forward to continuing advancing our portfolio with Dr. Papier and his team at VisualDx to bring medical advances to space travel.”